Opportunity Information: Apply for RFA MH 19 100

The National Institute of Mental Health (NIMH) Career Enhancement Award to Advance Autism Services for Adults and Transition-Age Youth is a K18 Research Career Enhancement Award opportunity (RFA-MH-19-100) aimed at established, independent investigators who want to pivot, broaden, or modernize their research programs by gaining expertise outside their current specialty. The core idea is to help experienced researchers acquire new skills, methods, and substantive knowledge that will make them more capable of conducting high-quality services research focused on adults and transition-age youth with Autism Spectrum Disorders (ASD). Rather than functioning like a typical large research grant, this mechanism emphasizes a structured career development and research training plan paired with a modest, small-scale research project that serves as a hands-on platform for building those new competencies.

This FOA is specifically limited to projects that do not involve the applicant leading an independent clinical trial. In practice, that means applicants cannot propose to be the lead investigator for a clinical trial, a clinical trial feasibility study, or an ancillary study attached to a clinical trial under this particular announcement. However, the FOA does allow a candidate to gain research experience within a clinical trial if that trial is led by a mentor or co-mentor, which is meant to support skill-building without placing the applicant in the role of trial leader. Investigators who do want to lead a clinical trial or propose an ancillary study as the lead should be directed to the companion announcement referenced in the text (RFA-MH-19-101), which is structured for clinical trial leadership.

Eligibility is intentionally broad on the institutional side and is aligned with common NIH practices, allowing applications from many types of U.S.-based organizations. Eligible applicant organizations include public and private institutions of higher education, nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), small businesses, and multiple levels of government entities such as state, county, city or township governments, special district governments, and independent school districts. It also includes federally recognized Native American tribal governments, tribal organizations that are not federally recognized, public housing authorities/Indian housing authorities, and a range of mission-specific institutional categories highlighted in the announcement such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs). Faith-based and community-based organizations and eligible federal government agencies are also listed as eligible applicants, along with U.S. territories or possessions.

At the same time, the FOA places clear restrictions on foreign involvement. Non-domestic (non-U.S.) entities and non-U.S. institutions are not eligible to apply, and non-domestic components of U.S. organizations are not eligible either. In addition, foreign components, as NIH defines them in its Grants Policy Statement, are not allowed under this opportunity. These restrictions mean the work and organizational footprint supported by the award must remain fully within allowable U.S.-based structures.

Administratively, this is a discretionary NIH grant program within the health funding activity category and is associated with CFDA number 93.242. The opportunity was created on July 3, 2018, and the original closing date listed is June 21, 2019. The announcement text does not provide an award ceiling or expected number of awards in the provided source data, so applicants would typically look to the full FOA for budget structure, project period limits, and any institute-specific funding expectations. Overall, the opportunity is best understood as a targeted mid-career or senior investigator retooling mechanism: it funds a deliberate training and mentorship plan plus a contained research effort, all oriented toward strengthening the evidence base and improving services for adults and transition-age youth on the autism spectrum, while explicitly avoiding applicant-led clinical trial designs under this particular FOA.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIMH Career Enhancement Award to Advance Autism Services for Adults and Transition-Age Youth (K18 Clinical Trials Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2018-07-03.
  • Applicants must submit their applications by 2019-06-21. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA MH 19 100

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is this funding opportunity?

This opportunity is the National Institute of Mental Health (NIMH) Career Enhancement Award to Advance Autism Services for Adults and Transition-Age Youth. It is a K18 Research Career Enhancement Award under FOA RFA-MH-19-100.

Who is this award designed for?

It is aimed at established, independent investigators (mid-career or senior level) who want to pivot, broaden, or modernize their research programs by gaining expertise outside their current specialty.

What is the main goal of the K18 (RFA-MH-19-100)?

The goal is to help experienced investigators acquire new skills, methods, and substantive knowledge that strengthen their ability to conduct high-quality services research focused on adults and transition-age youth with Autism Spectrum Disorders (ASD).

Is this a typical large research grant?

No. This mechanism emphasizes a structured career development and research training plan paired with a modest, small-scale research project. The small project serves as a hands-on platform for building new competencies rather than functioning like a large standalone research award.

What population and topic area does the FOA focus on?

The focus is on services research for adults and transition-age youth with Autism Spectrum Disorders (ASD), with the intent of improving the evidence base and strengthening autism-related services for these groups.

What types of activities are supported?

Based on the description provided, the supported activities include (1) a deliberate research training and mentorship plan designed to build expertise outside the investigator's current specialty, and (2) a modest, small-scale research project that enables practical skill-building in the targeted area.

Can the applicant lead an independent clinical trial under this FOA?

No. This FOA is specifically limited to projects that do not involve the applicant leading an independent clinical trial.

Are clinical trial feasibility studies allowed if the applicant is the lead?

No. Applicants cannot propose to be the lead investigator for a clinical trial feasibility study under this announcement.

Can the applicant lead an ancillary study attached to a clinical trial?

No. Applicants cannot propose to be the lead investigator for an ancillary study attached to a clinical trial under this particular announcement.

Is any clinical trial-related experience allowed at all?

Yes. The FOA allows a candidate to gain research experience within a clinical trial as part of their training, as long as the clinical trial is led by a mentor or co-mentor. The intent is skill-building without placing the applicant in the role of trial leader.

What should investigators do if they want to lead a clinical trial or lead an ancillary study?

Investigators who want to lead a clinical trial or propose an ancillary study as the lead are directed to the companion announcement referenced in the text: RFA-MH-19-101.

What types of organizations are eligible to apply?

Eligibility is broad for U.S.-based organizations. The listed eligible applicant organizations include public and private institutions of higher education, nonprofits (501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), small businesses, and a wide range of government entities (state, county, city or township governments; special district governments; and independent school districts). The eligible list also includes federally recognized Native American tribal governments, tribal organizations that are not federally recognized, public housing authorities/Indian housing authorities, eligible federal government agencies, and U.S. territories or possessions.

Are minority-serving institutions included as eligible applicants?

Yes. The announcement highlights eligibility for categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs).

Are faith-based or community-based organizations eligible to apply?

Yes. Faith-based and community-based organizations are listed as eligible applicants.

Are non-U.S. (foreign) organizations eligible to apply?

No. Non-domestic (non-U.S.) entities and non-U.S. institutions are not eligible to apply.

Can a U.S. organization apply if the project has a non-domestic component?

No. Non-domestic components of U.S. organizations are not eligible under this opportunity.

Are foreign components allowed under this FOA?

No. Foreign components (as NIH defines them in its Grants Policy Statement) are not allowed under this opportunity.

What do the foreign restrictions mean in practical terms?

They mean the work and the organizational footprint supported by the award must remain within allowable U.S.-based structures, without non-U.S. applicant entities, non-domestic organizational components, or NIH-defined foreign components.

Which NIH institute is sponsoring this FOA?

The sponsoring institute is the National Institute of Mental Health (NIMH).

What is the CFDA number associated with this opportunity?

The opportunity is associated with CFDA number 93.242.

What funding activity category is this program associated with?

It is described as a discretionary NIH grant program within the health funding activity category.

When was this opportunity created, and what is the closing date listed?

The opportunity was created on July 3, 2018, and the original closing date listed is June 21, 2019.

Does the provided information include an award ceiling or expected number of awards?

No. The provided source information does not include an award ceiling or an expected number of awards.

Where would an applicant typically look for budget structure and project period limits?

The description indicates that applicants would typically look to the full FOA for budget structure, project period limits, and any institute-specific funding expectations, because those details are not included in the provided source data.

How should this award be understood overall?

It is best understood as a targeted retooling mechanism for established investigators: it supports a deliberate training and mentorship plan plus a contained research effort, all oriented toward improving services research for adults and transition-age youth on the autism spectrum, while explicitly avoiding applicant-led clinical trial designs under this particular FOA.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Countering Weapons of Mass Destruction: Transformative Solutions Incubator (TSI)

Previous opportunity: Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA MH 19 100

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA MH 19 100) also looked into and applied for these:

Funding Opportunity
The National Health and Aging Trends Study (U01 Clinical Trial Not Allowed) Apply for RFA AG 19 019

Funding Number: RFA AG 19 019
Agency: National Institutes of Health
Category: Health
Funding Amount: $550,000
NIBIB Supplements to NCATS CTSA Programs to Support NIBIB Translational Research Scholars (Admin Supp Clinical Trials Optional) Apply for PA 18 851

Funding Number: PA 18 851
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: NIDCD National Temporal Bone, Hearing and Balance Pathology Resource Registry (U24 Clinical Trial Not Allowed) Apply for RFA DC 19 002

Funding Number: RFA DC 19 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $425,000
Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required) Apply for RFA AI 18 036

Funding Number: RFA AI 18 036
Agency: National Institutes of Health
Category: Health
Funding Amount: $10,000,000
Encouraging Development of Novel Amelogenesis Models (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA DE 19 004

Funding Number: RFA DE 19 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Cooperative Agreement to Support Navigators in Federally-facilitated Exchanges Apply for CA NAV 18 001

Funding Number: CA NAV 18 001
Agency: CMS-Consumer Information Insurance Oversight
Category: Health
Funding Amount: Case Dependent
Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed) Apply for PA 18 859

Funding Number: PA 18 859
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed) Apply for PA 18 858

Funding Number: PA 18 858
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required) Apply for RFA HL 19 025

Funding Number: RFA HL 19 025
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed) Apply for PAR 18 864

Funding Number: PAR 18 864
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed) Apply for PAR 18 860

Funding Number: PAR 18 860
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed) Apply for RFA HL 19 026

Funding Number: RFA HL 19 026
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed) Apply for PAR 18 865

Funding Number: PAR 18 865
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33 Clinical Trial Not Allowed) Apply for RFA AR 19 013

Funding Number: RFA AR 19 013
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 18 021

Funding Number: RFA RM 18 021
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed) Apply for PAR 18 866

Funding Number: PAR 18 866
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed) Apply for RFA RM 18 030

Funding Number: RFA RM 18 030
Agency: National Institutes of Health
Category: Health
Funding Amount: $8,000,000
Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed) Apply for PA 18 867

Funding Number: PA 18 867
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed) Apply for PA 18 868

Funding Number: PA 18 868
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research Innovations for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33 Clinical Trial Not Allowed) Apply for RFA AR 19 012

Funding Number: RFA AR 19 012
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 19 100", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: